Artwork

Content provided by DC EKG and Evergreen Podcasts | Big Whig Media. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by DC EKG and Evergreen Podcasts | Big Whig Media or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

DC EKG: Talks with David Senior Part III

20:37
 
Share
 

Manage episode 376629852 series 3439064
Content provided by DC EKG and Evergreen Podcasts | Big Whig Media. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by DC EKG and Evergreen Podcasts | Big Whig Media or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Common misconceptions and why pharmaceutical market is so different. List price, co pays and deductibles, oh my. Bio similars v small molecule, how the evolution here promises great things. Competition is real and generates real savings, and deflation. Opportunity for savings was real, IRA causing disruption to that. Cell and gene therapies are just the latest revolution for patients therapies: branded drugs, generic medicines, small molecule, bio similar. Who pays for these high cost, high reward solutions. How does performance play a role?

  continue reading

81 episodes

Artwork
iconShare
 
Manage episode 376629852 series 3439064
Content provided by DC EKG and Evergreen Podcasts | Big Whig Media. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by DC EKG and Evergreen Podcasts | Big Whig Media or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Common misconceptions and why pharmaceutical market is so different. List price, co pays and deductibles, oh my. Bio similars v small molecule, how the evolution here promises great things. Competition is real and generates real savings, and deflation. Opportunity for savings was real, IRA causing disruption to that. Cell and gene therapies are just the latest revolution for patients therapies: branded drugs, generic medicines, small molecule, bio similar. Who pays for these high cost, high reward solutions. How does performance play a role?

  continue reading

81 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide